Caplacizumab Interactions
There are 155 drugs known to interact with caplacizumab, along with 2 disease interactions. Of the total drug interactions, 68 are major, 81 are moderate, and 6 are minor.
- View caplacizumab disease interactions (2)
Medications known to interact with caplacizumab
Note: Showing generic names only.
A
- abciximab
- abrocitinib
- acalabrutinib
- ado-trastuzumab emtansine
- alemtuzumab
- alteplase
- anacaulase topical
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- aspirin
- avapritinib
B
C
- cabozantinib
- calaspargase pegol
- cangrelor
- capsicum
- celecoxib
- chamomile
- cilostazol
- citalopram
- clomipramine
- clopidogrel
- clove
- collagenase clostridium histolyticum
D
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dipyridamole
- dong quai
- drotrecogin alfa
- duloxetine
E
- edoxaban
- efgartigimod alfa
- enoxaparin
- epoprostenol
- eptifibatide
- escitalopram
- etodolac
- evening primrose
F
- fedratinib
- fenfluramine
- fenoprofen
- fenugreek
- feverfew
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
G
H
I
K
L
M
N
O
P
- panobinostat
- paroxetine
- pegaspargase
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- pirtobrutinib
- plasminogen, human
- ponatinib
- prasugrel
- protein c
R
S
T
- tafasitamab
- tazemetostat
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- treprostinil
- turmeric
U
V
W
Z
Caplacizumab disease interactions
There are 2 disease interactions with caplacizumab which include:
More about caplacizumab
- caplacizumab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.